Science
Mechanism of Action
Rhododendrol functions by competitively inhibiting tyrosinase, a key enzyme in melanin synthesis. Critically, it also acts as a substrate for tyrosinase, metabolizing into cytotoxic products such as RD-quinone. These reactive species induce melanocyte death through various pathways, including binding to sulfhydryl proteins (leading to ER stress), generating pro-oxidant rhododendrol-derived melanins (causing oxidative stress), and impairing melanocyte proliferation via ROS-dependent GADD45 activation. UV exposure has been shown to exacerbate its cytotoxicity.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Clinical reports and epidemiological surveys in Japan identified a higher frequency of leukoderma in individuals using cosmetics with 2% rhododendrol, leading to product withdrawal.
- 02 A patch test with 2% rhododendrol in petrolatum resulted in a positive reaction in 13.5% (25/185) of tested patients.
- 03 Daily application of 30% rhododendrol in hk14-SCF transgenic hairless mice induced depigmentation and melanocyte loss within 14 days.
Transparency
Dusting Analysis
Rhododendrol was deliberately used as an active ingredient for skin lightening. However, concentrations as low as 2% were directly linked to widespread chemical depigmentation (leukoderma), leading to its market withdrawal. Its primary hazard is severe melanocyte cytotoxicity, rather than simply being ineffective at low doses.
The Formula
Formulation
Stability
Rhododendrol is heat-sensitive, requiring storage below 0°C. Its oxidation product, RD-quinone, is highly unstable, undergoing further unstable conversions, particularly rapidly at acidic pH (below pH 1).
Conflicts
- UV light (increases cytotoxicity)
- Low pH (causes RD-quinone instability)
Safety
Safety Profile
Rhododendrol was withdrawn from the market in 2013 due to widespread reports of inducing leukoderma (chemical depigmentation), even at concentrations of 2%. Its main hazard is severe melanocyte cytotoxicity. No official 'safe as used' status has been established by regulatory bodies; instead, its use led directly to severe adverse effects and product withdrawal.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its tyrosinase inhibiting properties, rhododendrol's severe and widespread melanocyte cytotoxicity, leading to permanent depigmentation, makes it an ingredient to unequivocally avoid in skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources